Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on

Qi Wang1, Kang-Yu Chen1, Fei Yu1

  • 1Department of Cardiology, Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui, China.

Insights

Heart failure etiology impacts cardiac resynchronization therapy benefits. Patients with ischemic cardiomyopathy and severe diastolic dysfunction showed poorer responses to CRT, highlighting the role of diastolic function in treatment outcomes.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Medical Device Technology

Background:

  • Cardiac resynchronization therapy (CRT) is a key treatment for heart failure.
  • The effectiveness of CRT can vary based on the underlying cause of heart failure.
  • Diastolic function's role in CRT outcomes requires further investigation.

Purpose of the Study:

  • To explore the association between diastolic function and CRT benefits.
  • To compare CRT effects in patients with ischemic versus non-ischemic cardiomyopathy.
  • To identify factors influencing CRT response based on heart failure etiology.

Main Methods:

  • 104 heart failure patients were categorized into ischemic (n=27) and non-ischemic (n=77) cardiomyopathy groups.
  • Left ventricular diastolic function was assessed via echocardiography pre-implantation.
  • CRT effects were evaluated at six months using clinical and echocardiographic parameters.

Main Results:

  • Ischemic cardiomyopathy patients had more restrictive filling patterns.
  • Non-ischemic cardiomyopathy patients demonstrated significantly higher CRT response rates and improved echocardiographic parameters.
  • Restrictive filling was identified as an independent factor affecting CRT response.

Conclusions:

  • Heart failure etiology significantly influences CRT outcomes.
  • Ischemic cardiomyopathy is associated with more severe diastolic dysfunction and reduced CRT benefits.
  • Severe diastolic dysfunction in systolic heart failure predicts poor CRT response.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
632
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K